• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的衰弱和认知障碍:系统综述。

Frailty and cognitive impairment in Parkinson's disease: a systematic review.

机构信息

Department of Surgery and Medical-Surgical Specialties, Faculty of Medicine and Health Sciences, University of Oviedo, 33006, Oviedo, Spain.

Department of Functional Biology and Health Sciences, Faculty of Physiotherapy, Universidade de Vigo, 36005, Pontevedra, Spain.

出版信息

Neurol Sci. 2022 Dec;43(12):6693-6706. doi: 10.1007/s10072-022-06347-7. Epub 2022 Sep 2.

DOI:10.1007/s10072-022-06347-7
PMID:36056182
Abstract

BACKGROUND

Frailty can lead to increased vulnerability in older people and patients with Parkinson's disease (pwPD) and worsen their health conditions. These patients can also develop cognitive function impairment. The objective is to analyze whether there is a relationship between frailty and cognitive impairment in pwPD, and to find out which instruments to use for its evaluation.

METHODS

Publications were searched in PubMed, Medline, Web of Science, Cinalh, Cochrane Library, Embase, Phycinfo, and Scopus. The results were measured with the instruments that are used to assess frailty and cognitive impairment, and analyze their relationship.

RESULTS

Two hundred seventy-one articles were identified, of which 12 met the inclusion criteria. All studies assessed frailty and cognitive function in pwPD. Five studies analyzed the relationship between frailty and cognitive impairment. The most used instruments were the Fried scale followed by the Clinical Frailty Scale (CFS) for frailty. Cognitive impairment was mostly evaluated with the Mini-Mental State Examination and the Montreal Cognitive Assessment. The prevalence data ranged from 20.2 to 51.5% with the Fried scale and from 35.6 to 83.9% with the CFS. Cognitive impairment was present in 15 to 45.2% of the pwPD.

CONCLUSION

Analysis of the included studies shows a relationship between frailty and cognitive impairment in pwPD. There was significant variability in the application of the scales used, which influences the prevalence data. More observational and experimental studies are needed to provide more evidence on this association and to determine which is the optimal tool to identify frailty in pwPD using multidimensional scales.

摘要

背景

衰弱可导致老年人和帕金森病患者(pwPD)的脆弱性增加,并使他们的健康状况恶化。这些患者还可能出现认知功能障碍。目的是分析 pwPD 中衰弱与认知障碍之间是否存在关系,并找出评估衰弱的工具。

方法

在 PubMed、Medline、Web of Science、Cinalh、Cochrane Library、Embase、Phycinfo 和 Scopus 中搜索出版物。使用评估衰弱和认知障碍的工具来衡量结果,并分析它们之间的关系。

结果

确定了 271 篇文章,其中 12 篇符合纳入标准。所有研究均评估了 pwPD 的衰弱和认知功能。五项研究分析了衰弱和认知障碍之间的关系。最常用的工具是 Fried 量表,其次是临床衰弱量表(CFS)用于评估衰弱。认知障碍主要用简易精神状态检查和蒙特利尔认知评估进行评估。使用 Fried 量表时,衰弱的患病率数据范围为 20.2%至 51.5%,使用 CFS 时,衰弱的患病率数据范围为 35.6%至 83.9%。pwPD 中有 15%至 45.2%存在认知障碍。

结论

对纳入研究的分析表明,pwPD 中衰弱与认知障碍之间存在关系。所使用量表的应用存在显著差异,这影响了患病率数据。需要更多的观察性和实验性研究来提供更多关于这种关联的证据,并确定使用多维量表识别 pwPD 衰弱的最佳工具。

相似文献

1
Frailty and cognitive impairment in Parkinson's disease: a systematic review.帕金森病患者的衰弱和认知障碍:系统综述。
Neurol Sci. 2022 Dec;43(12):6693-6706. doi: 10.1007/s10072-022-06347-7. Epub 2022 Sep 2.
2
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
3
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.抗胆碱能负担预测轻度认知障碍或痴呆老年患者认知下降或神经精神症状。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD015196. doi: 10.1002/14651858.CD015196.pub2.
4
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
5
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
6
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
8
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
9
Occupational therapy for cognitive impairment in stroke patients.脑卒中患者认知障碍的作业治疗。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Neuroimaging Findings in Nondemented Frail Individuals: A Systematic Review.非痴呆体弱个体的神经影像学研究结果:一项系统综述
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13719. doi: 10.1002/jcsm.13719.
2
Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study.帕金森病中衰弱与认知障碍之间的关联:一项横断面研究。
Aging Clin Exp Res. 2025 Jan 3;37(1):19. doi: 10.1007/s40520-024-02922-4.
3
Cross-Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin America.

本文引用的文献

1
Similarities, differences and overlaps between frailty and Parkinson's disease.衰弱与帕金森病之间的异同与重叠
Geriatr Gerontol Int. 2022 Apr;22(4):259-270. doi: 10.1111/ggi.14362. Epub 2022 Mar 3.
2
Frailty in Patients with Parkinson's Disease: Associations with Disability and Timed Up and Go.帕金森病患者的衰弱:与残疾及计时起立行走测试的关联
Noro Psikiyatr Ars. 2019 Nov 11;58(3):206-212. doi: 10.29399/npa.23444. eCollection 2021.
3
Frailty in Parkinson's disease: A systematic review and meta-analysis.帕金森病中的衰弱:一项系统综述与荟萃分析。
拉丁美洲帕金森综合征、帕金森病与衰弱之间的横断面及前瞻性关联
Mov Disord Clin Pract. 2024 Dec;11(12):1489-1499. doi: 10.1002/mdc3.14214. Epub 2024 Sep 20.
4
Influence of frailty status on the health-related quality of life in older patients with chronic low back pain: a retrospective observational study.衰弱状况对慢性腰痛老年患者健康相关生活质量的影响:一项回顾性观察研究。
Qual Life Res. 2024 Jul;33(7):1905-1913. doi: 10.1007/s11136-024-03658-4. Epub 2024 Apr 20.
5
Facial emotion expressivity in patients with Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病患者的面部表情表达能力。
J Neural Transm (Vienna). 2024 Jan;131(1):31-41. doi: 10.1007/s00702-023-02699-2. Epub 2023 Oct 7.
6
COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection.新冠病毒与神经系统疾病:帕金森病与新冠病毒感染之间可能存在何种关联。
Front Neurol. 2023 May 18;14:1172416. doi: 10.3389/fneur.2023.1172416. eCollection 2023.
7
The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.肠道微生物群与帕金森病的相互作用:对诊断和治疗的影响。
Int J Mol Sci. 2022 Oct 14;23(20):12289. doi: 10.3390/ijms232012289.
Clin Park Relat Disord. 2021 May 25;4:100095. doi: 10.1016/j.prdoa.2021.100095. eCollection 2021.
4
Physical Frailty and Cognitive Impairment in Older Adults in United States Nursing Homes.美国养老院中老年人的身体虚弱和认知障碍。
Dement Geriatr Cogn Disord. 2021;50(1):60-67. doi: 10.1159/000515140. Epub 2021 Apr 22.
5
Cognitive impairment and physical frailty in older adults in secondary health care.中老年人群在二级医疗保健中的认知障碍和身体虚弱。
Rev Esc Enferm USP. 2021 Apr 16;55:e03687. doi: 10.1590/S1980-220X2019029803687. eCollection 2021.
6
The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance.肠脑轴与帕金森病:临床与发病机制相关性。
Ann Med. 2021 Dec;53(1):611-625. doi: 10.1080/07853890.2021.1890330.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease.基于申报的衰弱和结局:将一种衰老衡量标准应用于老年帕金森病患者。
Mov Disord. 2021 Aug;36(8):1871-1878. doi: 10.1002/mds.28561. Epub 2021 Mar 23.
9
The Association Between Frailty and Parkinson's Disease in the ReSPOnD Trial.ReSPOnD试验中衰弱与帕金森病之间的关联
Can Geriatr J. 2021 Mar 2;24(1):22-25. doi: 10.5770/cgj.24.437. eCollection 2021 Mar.
10
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.帕金森病中的肠道微生物生态系统:多组学带来的新临床生物学见解。
Ann Neurol. 2021 Mar;89(3):546-559. doi: 10.1002/ana.25982. Epub 2021 Jan 11.